SCHEMBL2492279

SCHEMBL2492279

CCCOc1ccccc1[C](c1ccccc1OCCC)c1ccccc1OCCC

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.53
KMT2A Q03164 3/20 0.53
MEN1 O00255 2/20 0.53
MAPT P10636 2/20 0.53
NR1I2 O75469 1/20 0.53
CHRM2 P08172 1/20 0.53
CYP3A4 P08684 1/20 0.53
ADRA2A P08913 1/20 0.53
OPRK1 P41145 1/20 0.53
HTR2B P41595 1/20 0.53
SLC6A3 Q01959 1/20 0.53
HDAC6 Q9UBN7 1/20 0.53
HIF1A Q16665 1/20 0.51
ALDH1A1 P00352 5/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
KDM4E B2RXH2 2/20 0.50
PTK2B Q14289 1/20 0.47
ADRB2 P07550 1/20 0.47
ADRB1 P08588 1/20 0.47
ADRB3 P13945 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2494574 0.90 LMNA (0.60) LMNAKMT2AMEN1MAPTNR1I2
SCHEMBL4362613 0.89 KMT2A (0.50) LMNAKMT2AMEN1MAPTNR1I2
SCHEMBL4367374 0.89 KMT2A (0.50) LMNAKMT2AMEN1MAPTNR1I2
SCHEMBL2490797 0.83 HCRTR1 (0.59) LMNAKMT2AMEN1MAPTALDH1A1
SCHEMBL124950 0.82 ALDH1A1 (0.71) LMNAKMT2AMEN1MAPTNR1I2
SCHEMBL3135517 0.82 LMNA (0.74) LMNAKMT2AMEN1MAPTNR1I2
SCHEMBL31643582 0.82 ALDH1A1 (0.71) LMNAKMT2AMEN1MAPTNR1I2
1,2-Dipropoxybenzene SCHEMBL29428926 0.82 CYP1A2 (0.56) LMNAKMT2AMEN1MAPTHTR2B
1,2-Dipropoxybenzene SCHEMBL578657 0.82 CYP1A2 (0.56) LMNAKMT2AMEN1MAPTHTR2B
SCHEMBL1985 0.81 LMNA (0.55) LMNAKMT2AMEN1MAPTNR1I2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2380567-B1 MELANIN PRODUCTION INHIBITOR POLA CHEM IND INC (JP) 2019-01-16 EP disclosed
EP-3009123-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2016-04-20 EP disclosed
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2015-11-19 US disclosed
EP-2845587-A2 Melanin production inhibitor Pola Chemical Industries Inc. (JP) 2015-03-11 EP disclosed
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2014-12-11 US disclosed
US-8846012-B2 Melanin production inhibitor POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-30 US disclosed
EP-2380567-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2011-10-26 EP disclosed
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, TH LMNA 2547/4885KMT2A 2108/4885MEN1 1585/4885
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR TYR, MC1R, F12 LMNA 2843/4885KMT2A 2219/4885MEN1 1346/4885
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, MC1R LMNA 2187/4885KMT2A 2287/4885MEN1 1200/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.